ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia

被引:8
|
作者
Otto, N. [1 ]
Manukjan, G. [1 ]
Goehring, G. [1 ]
Hofmann, W. [1 ]
Scherer, R. [2 ]
Luna, J. Chacon [1 ]
Lehmann, U. [3 ]
Ganser, A. [4 ]
Welte, K. [5 ]
Schlegelberger, B. [1 ]
Steinemann, D. [1 ]
机构
[1] Hannover Med Sch, Inst Cell & Mol Pathol, D-3000 Hannover, Germany
[2] Hannover Med Sch, Inst Biometry, D-3000 Hannover, Germany
[3] Hannover Med Sch, Inst Pathol, D-3000 Hannover, Germany
[4] Hannover Med Sch, Dept Haematol Haemostasis Oncol & Stem Cell Trans, D-3000 Hannover, Germany
[5] Hannover Med Sch, Ctr Paediat & Adolescent Med & Dermatol, D-3000 Hannover, Germany
关键词
SEQUENCE-BINDING-PROTEIN; MYELOGENOUS LEUKEMIA; CELLS; EXPRESSION; GENE; APOPTOSIS; TRANSCRIPTION; SURVIVAL; MUTATION; MICE;
D O I
10.1038/leu.2011.61
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1202 / 1207
页数:6
相关论文
共 50 条
  • [42] Vorinostat in acute myeloid leukemia and myelodysplastic syndromes
    Prebet, Thomas
    Vey, Norbert
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (02) : 287 - 295
  • [43] Aberrant p15 gene promoter methylation in therapy-related myelodysplastic syndrome and acute myeloid leukaemia:: clinicopathological and karyotypic associations
    Au, WY
    Fung, A
    Man, C
    Ma, SK
    Wan, TS
    Liang, R
    Kwong, YL
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (06) : 1062 - 1065
  • [44] MOLECULAR DIFFERENCES BETWEEN MYELOID LINEAGE NEOPLASMS (ACUTE MYELOID LEUKAEMIA, MYELODYSPLASTIC SYNDROMES AND MYELOPROLIFERATIVE NEOPLASMS) AND THEIR CLINICAL IMPLICATIONS
    Gonzalez, A.
    Alvarez, N.
    Morales, M. L.
    Carreno, G.
    Onecha, E.
    Sanchez, R.
    Espino, M. J.
    Tejero, F.
    Linares, M.
    Martinez, P.
    Cedena, T.
    Rapado, I
    Martinez-Lopez, J.
    Ayala, R.
    HAEMATOLOGICA, 2020, 105 : 44 - 45
  • [46] Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology
    Della Porta, Matteo G.
    Bewersdorf, Jan Philipp
    Wang, Yu-Hung
    Hasserjian, Robert P.
    HISTOPATHOLOGY, 2025, 86 (01) : 158 - 170
  • [47] Impact of TET2 mutations on response to Azacytidine in myelodysplastic syndromes and acute pauciblastic myeloid leukaemia
    Perot, Christine
    HEMATOLOGIE, 2011, 17 (05): : 313 - 314
  • [48] Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics
    Trost, D
    Hildebrandt, B
    Müller, N
    Germing, U
    Royer-Pokora, B
    LEUKEMIA RESEARCH, 2004, 28 (02) : 171 - 177
  • [49] Models to study myelodysplastic syndrome and acute myeloid leukaemia
    Chao, Clifford
    Martinez, Isabella G.
    Wagenblast, Elvin
    CURRENT OPINION IN HEMATOLOGY, 2025, 32 (02) : 87 - 92
  • [50] Methylation and myelodysplastic syndromes
    Couturier, Marie-Anne
    Itzykson, Raphael
    Colombat, Philippe
    Gyan, Emmanuel
    HEMATOLOGIE, 2010, 16 : 12 - 16